A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure

NCT01096043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Placebo
DRUG: Strata 1 CXL-1020
DRUG: Strata 2 CXL-1020
DRUG: Strata 3 CXL-1020

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]